Skip to main content

Peer Review reports

From: Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917)

Original Submission
17 Nov 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Dec 2020 Reviewed Reviewer Report
29 Dec 2020 Reviewed Reviewer Report - Christian Jackisch
30 Mar 2021 Author responded Author comments - Takahiro Nakayama
Resubmission - Version 3
30 Mar 2021 Submitted Manuscript version 3
2 Apr 2021 Author responded Author comments - Takahiro Nakayama
Resubmission - Version 4
2 Apr 2021 Submitted Manuscript version 4
6 Apr 2021 Reviewed Reviewer Report
3 May 2021 Reviewed Reviewer Report - Christian Jackisch
18 May 2021 Author responded Author comments - Takahiro Nakayama
Resubmission - Version 5
18 May 2021 Submitted Manuscript version 5
21 May 2021 Author responded Author comments - Takahiro Nakayama
Resubmission - Version 6
21 May 2021 Submitted Manuscript version 6
Publishing
10 Jun 2021 Editorially accepted
9 Jul 2021 Article published 10.1186/s12885-021-08504-1

You can find further information about peer review here.

Back to article page